Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
The Ulster Medical Journal|April 1, 1991
Human immunodeficiency virus infection in Northern Ireland 1980-1989R D Maw, J H Connolly, E E Mayne, et al.
Neurology|January 6, 2012
Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against EpilepsyG L Birbeck, J A French, E Perucca, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM Naumann, Y So, C E Argoff, et al.
International Journal of STD & AIDS|August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilisC M Marra, R Deutsch, A C Collier, et al.
Neurology|January 10, 2002
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathyM Polydefkis, C T Yiannoutsos, B A Cohen, et al.
Neurology|February 20, 1999
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathyD B Clifford, C Yiannoutsos, M Glicksman, et al.
Neurology|June 14, 2006
HIV neuropathy natural history cohort study: assessment measures and risk factorsD M Simpson, D Kitch, S R Evans, et al.
Pain|September 21, 2010
Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathyJ Robinson-Papp, S Morgello, F Vaida, et al.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
The Journal of Infectious Diseases|June 3, 1999
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials GroupJ M Jacobson, J Spritzler, L Fox, et al.
Pageof 18